Company Overview - BGSF shares increased by 12.9% to $6.31 in the last trading session, with a notable trading volume, and have gained 25.6% over the past four weeks [1] - The company has agreed to sell its Professional Division to INSPYR Solutions for $99 million in cash, which includes IT consulting, finance & accounting, managed solutions, and near/offshore software services [1] Earnings Expectations - BGSF is expected to report break-even quarterly earnings per share (EPS), reflecting a year-over-year change of +100%, with revenues projected at $66.5 million, a decrease of 2.4% from the previous year [2] - The consensus EPS estimate for BGSF has been revised 100% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [3] Industry Comparison - BGSF is part of the Zacks Business - Services industry, where another company, Crawford & Company B, saw its stock rise by 2.2% to $10.19, but has returned -0.9% over the past month [3] - Crawford & Company B's consensus EPS estimate remains unchanged at $0.24, representing a -4% change compared to the previous year, and holds a Zacks Rank of 3 (Hold) [4]

Kimbell Royalty (KRP) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends ...

MRC Global (MRC) shares ended the last trading session 11.8% higher at $14.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.2% gain over the past four weeks.Shares of MRC Global rallied following the news of its planned acquisition by DNOW Inc. (DNOW) . The two entities inked a merger deal per which, DNOW will buy all outstanding shares of MRC Global for approximately $1.5 billion, which includes the latter’s ...

Enova International (ENVA) shares rallied 5.2% in the last trading session to close at $111.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.1% gain over the past four weeks.Enova International widens gains for seventh straight trading session. The rally was fueled by broad market optimism surrounding potential trade agreements and growing expectations of earlier-than-anticipated interest rate cuts by t ...

Company Overview - DMC Global (BOOM) shares increased by 12.4% in the last trading session, closing at $8.16, with notable trading volume compared to typical sessions, and a 6.9% gain over the past four weeks [1] - James O'Leary has been appointed as the permanent president and CEO, having served as interim since November 29, 2024, with a focus on deleveraging the balance sheet and restoring capital structure [2] Financial Performance - DMC Global is expected to report quarterly earnings of $0.05 per share, reflecting a year-over-year decline of 82.8%, with revenues projected at $150.8 million, down 11.9% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - DMC Global is part of the Zacks Industrial Services industry, where another company, Fastenal (FAST), saw a 1.6% increase in its stock price, closing at $41.96, with a 0.2% return over the past month [4] - Fastenal's consensus EPS estimate has increased by 0.6% over the past month to $0.28, representing a 12% change compared to the previous year's EPS [5]

Group 1 - IGC Pharma, Inc. reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.02, representing an earnings surprise of +50.00% [1] - The company posted revenues of $0.33 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 6.45%, compared to revenues of $0.29 million a year ago [2] - IGC Pharma has surpassed consensus EPS estimates three times over the last four quarters [2] Group 2 - The stock has underperformed the market, losing about 7.7% since the beginning of the year, while the S&P 500 gained 4.4% [3] - The current consensus EPS estimate for the coming quarter is -$0.03 on revenues of $0.33 million, and -$0.11 on revenues of $1.5 million for the current fiscal year [7] - The Zacks Industry Rank for Medical - Drugs is in the top 33% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

A month has gone by since the last earnings report for Salesforce.com (CRM) . Shares have added about 1.4% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Salesforce.com due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It tu ...

Company Overview - Flowserve (FLS) shares increased by 6.8% to close at $51.88, supported by strong trading volume, contrasting with a 3.8% decline over the past four weeks [1] - The company specializes in manufacturing pumps, valves, and other components for the oil and gas industries [3] Business Performance - The recent rally in Flowserve's stock is attributed to positive momentum in its aftermarket business, driven by robust demand across North America, Europe, the Middle East, and Latin America [2] - An increase in bookings in general industries, energy, and power end markets is bolstering the company's performance [2] Earnings Expectations - Flowserve is projected to report quarterly earnings of $0.77 per share, reflecting a year-over-year increase of 5.5% [3] - Expected revenues for the upcoming quarter are $1.21 billion, which represents a 4.7% increase compared to the same quarter last year [3] Market Sentiment - The consensus EPS estimate for Flowserve has remained stable over the last 30 days, indicating that stock price movements may not sustain without changes in earnings estimate revisions [5] - Flowserve currently holds a Zacks Rank of 3 (Hold), while IHI CORP, a competitor in the same industry, has a Zacks Rank of 1 (Strong Buy) [5][6]

Concentrix Corporation (CNXC) came out with quarterly earnings of $2.7 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.17%. A quarter ago, it was expected that this company would post earnings of $2.58 per share when it actually produced earnings of $2.79, delivering a surprise of +8.14%.Over the last four quarters, the co ...

Key Takeaways WBA posted Q3 adjusted EPS of $0.38, beating estimates but falling nearly 40% year over year. WBA reported $38.99B in Q3 sales, up 7.2% year over year and ahead of the consensus by 6.5%. The gross margin fell 108 bps to 16.7%. WBA withdrew fiscal 2025 guidance amid the pending Sycamore deal.Walgreens Boots Alliance, Inc. (WBA) delivered adjusted earnings per share (EPS) of 38 cents in the third quarter of fiscal 2025, down 39.7% from the year-ago quarter’s figure (down 39.6% at the constant ...